tailieunhanh - Báo cáo khoa học: "Pyoderma gangrenosum after totally implanted central venous access device insertion"

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Pyoderma gangrenosum after totally implanted central venous access device insertion | World Journal of Surgical Oncology BioMed Central Case report Open Access Pyoderma gangrenosum after totally implanted central venous access device insertion Ihsan Inan 1 Patrick O Myers1 Rolf Braun2 Monica E Hagen1 and Philippe Morel1 Address 1Visceral Surgery Unit Department of Surgery Geneva University Hospital Rue Micheli-du-Crest 24 CH-1211 Geneva Switzerland and 2Dermatology Department Geneva University Hospital Rue Micheli-du-Crest 24 CH-1211 Geneva Switzerland Email Ihsan Inan - Patrick O Myers - Rolf Braun - Monica E Hagen - Philippe Morel - Corresponding author Published 6 March 2008 Received 9 February 2008 World Journal of Surgical Oncology 2008 6 31 doi 1477-7819-6-3 1 Accepted 6 March 2008 This article is available from http content 6 1 31 2008 Inan et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background Pyoderma gangrenosum is an aseptic skin disease. The ulcerative form of pyoderma gangrenosum is characterized by a rapidly progressing painful irregular and undermined bordered necrotic ulcer. The aetiology of pyoderma gangrenosum remains unclear. In about 70 of cases it is associated with a systemic disorder most often inflammatory bowel disease haematological disease or arthritis. In 25-50 of cases a triggering factor such as recent surgery or trauma is identified. Treatment consists of local and systemic approaches. Systemic steroids are generally used first. If the lesions are refractory steroids are combined with other immunosuppressive therapy or to antimicrobial agents. Case presentation A 90 years old patient with myelodysplastic syndrome seeking regular .

TÀI LIỆU LIÊN QUAN
crossorigin="anonymous">
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.